Navigation Links
VAP Test Demonstrates Value of Fish Oil in Reducing Heart Risk for Super Bowl Champs
Date:2/19/2009

Advanced cholesterol test helps usher in new era of specialized test for cardiac risk assessment

BIRMINGHAM, Ala., Feb. 19 /PRNewswire/ -- For the Pittsburgh Steelers, adding a heart-healthy supplement to their diet may have given them the boost to win Super Bowl XLIII. That's according to a clinical study proving that fish oils dramatically improve cholesterol levels in professional football players. Findings were published January in the inaugural issue of Sports Health: A Multi-Disciplinary Approach.

The two-year study titled Evaluation of Lipid Profiles and the Use of Omega-3 Essential Fatty Acid in Professional Football Players evaluated 36 professional NFL football players, ages 23 to 41, from the Pittsburgh Steelers. Researchers assessed emerging cardiovascular risk factors, as found in the specialized VAP(R) Cholesterol Test, to determine whether omega-3 EFAs (essential fatty acids) found in fish oil can reduce these factors.

During a two month period of the regular 2006-2007 football season, each participant in the treatment group was given 2,560 mg/day of mixed EPA/DHA omega-3 fatty acid supplements in the form of fish oil soft gels.

Results showed that the omega-3 oil raised the athletes' high-density lipoproteins (HDL--good cholesterol) and lowered triglycerides and other atherogenic subfractions. Elevated levels of triglycerides are associated with diabetes and cardiovascular disease. These results suggest a strong benefit for lessening heart disease risk factors in football players and possibly other athletes throughout their active years, study authors said.

Measurement of emerging clinical and lipid risk factors in the study was done with the VAP (Vertical Auto Profile) Cholesterol Test from Atherotech, Inc. Such detailed cholesterol profiling has the ability to more accurately identify parents' true risk of heart disease, allowin
'/>"/>

SOURCE Atherotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. First Multiple Dose Clinical Trial of TorreyPines Therapeutics Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated
2. Epilepsia Study Demonstrates New Add-on Antiepileptic Drug Vimpat(R) (lacosamide) Significantly Reduces Partial-Onset Seizures in Adults With Epilepsy
3. Sparta Systems Demonstrates Global Enterprise Quality Management Leadership at TrackWise(R) Connection User Conferences
4. Human clinical study demonstrates superior Neptune Krill Oil NKO(R) pharmacokinetic profile
5. Antheras Varespladib Demonstrates Significant Anti-Inflammatory Effect and LDL Reduction in Patients With Coronary Heart Disease
6. RVX-208 Data Demonstrates Increase in Functional HDL Particles
7. Study From the University of Texas M.D. Anderson Cancer Center Demonstrates That AHCC(R) is Safe in Combination With Most Chemotherapeutic Agents
8. Vaxart Demonstrates Efficacy of Oral Avian Flu Vaccine in Preclinical Studies
9. EntreMeds ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
10. SuperGens MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy
11. SAFC Hitech(TM) Successfully Demonstrates Device-Quality GST Precursors For Phase Change Memory Applications

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Health care employment grew by 29,0... one to show consistent growth during the U.S. rec...emain in trouble, and health systems are coming cl...instead of just administrators. , ...employment continued growing in October despite th...
(Date:11/24/2009)..., SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- NOD P...Trademark Office (PTO) has allowed the patent appl... technology. , NOD technology is a highly...teins into bio-adhesive nano-particles to enable o...jections. NOD technology is a platform technology,...
(Date:11/24/2009)..., SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- Sha...p; Drug Administration (SFDA) has approved the,inv...al insulin project,(Nodlin), an innovative insulin...allows Biolaxy to initiate its first phase I clini...cteristic of high blood glucose and poor,metabolis...
(Date:11/24/2009)... The FBI recently approved the Promega...rticipating in or generating DNA records for the N... Madison, WI USA (PRWEB) -- The FBI recently app...r use by laboratories participating in, or generat... (NDIS). NDIS currently contains more than seven m...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...nc. , a designer and manufacturer of disk drives f...g completion of a 70,000 square foot plant additio...,Following its completion next month, Hutchinson w...ing developed by company engineers, and will tenta...arly 2007. , ,Connie Pautz, director of corporate ...
... the Governor,s Business Plan Contest, the Grand P...ge of its respective industry. This year,s field o... that continues the trend begun by start ups like ...evelopment and NovaScan, who tied for first in 200...ed on the first day of the annual Wisconsin Entrep...
... doctor may be losing a patient, but a significant...ironment of a hospital, there are hundreds of supp...e - a process that often leaves doctors rooting ar...ng from room to room in the hunt for a defibrillat... medical officer at BearingPoint, the hunt for sup...
Other Biology Technology:Hutchinson plant expansion nears completion 2Business plan finalists offer peek into entrepreneurial future 2Business plan finalists offer peek into entrepreneurial future 3RFID system aids hospital in tracking assets 2RFID system aids hospital in tracking assets 3
(Date:11/24/2009)...of debate. A high-profile study a few years ago su...arbon from trees and leaves, evidence for a very c...ystems. , But new research from the University o...Algae provide a much richer diet for fish and othe...is week in the Proceedings of the National Academ...
(Date:11/23/2009)...ed strain of the deadly superbug MRSAan infection-...icsposes a far greater health threat than previous...ording to a study in the December issue of Emergi...sily picked up in fitness centers, schools, and ot...rden of MRSA within hospitals, the report found. ,...
(Date:11/23/2009)...ants gathered this week for the seventh annual Nat.... This year,s topic, "Synthetic Biology," brought ...chers to explore the engineering, scientific, and ...nthetic biology. , Bonnie L. Bassler, professor ...his year,s conference chair, challenged the attend...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New study finds MRSA on the rise in hospital outpatients 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Free Upcoming Program Scheduled to Help Remove Barriers To Early Cervical and Breast Cancer Diagnosis for Local Women 58310 1Free Upcoming Program Scheduled to Help Remove Barriers To Early Cervical and Breast Cancer Diagnosis for Local Women 58310 2Free Upcoming Program Scheduled to Help Remove Barriers To Early Cervical and Breast Cancer Diagnosis for Local Women 58310 3Free Upcoming Program Scheduled to Help Remove Barriers To Early Cervical and Breast Cancer Diagnosis for Local Women 58310 4Gersten Savage Expands IP Practice With Partner Jason Lief 58308 1Gersten Savage Expands IP Practice With Partner Jason Lief 58308 2Oncolytics Biotech 28R 29 Inc Announces Reovirus and Cisplatin Research Supports U S Phase 2 Metastatic Melanoma Trial 14269 1Oncolytics Biotech 28R 29 Inc Announces Reovirus and Cisplatin Research Supports U S Phase 2 Metastatic Melanoma Trial 14269 2
...at Penn State University will reveal in the 29 Mar...plete high-resolution map of important structures ...throughout an entire genome. "For the first time,...-wide scale how nucleosomes control the expression...rofessor of biochemistry and molecular biology and...
... by scientists from the University of North Caroli...mechanism involved in the development of schizophr...f adults who had been diagnosed with schizophrenia...e-regulating molecules called microRNAs were lower...were free of psychiatric illness. , "In many ge...
...15th issue of Genes & Development, an internat...un Qi (National Institute of Biological Sciences, ...the unicellular green alga, Chlamydomonas reinhard...nicellular organism. , “The finding changes the d...nisms, and adds an important piece into the bloomi...
Other Biology News:Scientists reveal structure of gateways to gene control 2Scientists reveal structure of gateways to gene control 3Scientists reveal structure of gateways to gene control 4Brain tissue reveals possible genetic trigger for schizophrenia 2
Rabbit Anti-Human IRF7 Antibody, Unconjugated from ABR-Affinity BioReagents
Rabbit Anti-PI3K p110 delta (Poly6049) Polyclonal Antibody, Unconjugated from BioLegend
Rabbit Anti-Human Retinoic Acid-Induced 3 (RAI3 / RAIG1) Polyclonal Antibody, Unconjugated from IMGENEX
Mouse Anti-Human CD164 Antibody, Biotin Conjugated from BioLegend
Biology Products: